MedPath

The effect of carbon dioxide on inhaled antibiotics in bronchiectasis patients.

Conditions
Bronchiectasis
MedDRA version: 14.1Level: LLTClassification code 10006446Term: Bronchiectasis NOSSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
Registration Number
EUCTR2012-001541-40-NL
Lead Sponsor
Vu University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Bronchiectasis
Antibiotic inhalation treatment
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 11
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 3
;
Bronchiectasis
Antibiotic inhalation treatment
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 11
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 3

Exclusion Criteria

oAge <21 years.
oChronic respiratory insufficiency defined according to the GOLD criteria (PaO2 < 60 mmHg or PaCO2 > 50 mmHg, WHO Global Initiative for Chronic Obstructive Lung Disease 2006)
oRenal insufficiency defined as renal creatinine clearance of < 30 ml/minute.
oNeuromuscular diseases.
oImpaired hearing
oPregnant or breastfeeding.
oBronchiectasis exacerbation during last 4 weeks.
oHistory of panic attacks

;
oAge <21 years.
oChronic respiratory insufficiency defined according to the GOLD criteria (PaO2 < 60 mmHg or PaCO2 > 50 mmHg, WHO Global Initiative for Chronic Obstructive Lung Disease 2006)
oRenal insufficiency defined as renal creatinine clearance of < 30 ml/minute.
oNeuromuscular diseases.
oImpaired hearing
oPregnant or breastfeeding.
oBronchiectasis exacerbation during last 4 weeks.
oHistory of panic attacks

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath